Bio-defense accounts for the use of various medical procedures that help in protecting individuals against bioterrorism, which involves not only drugs and vaccinations but also research and various health preparations for the population for defending themselves against such biological attacks. Bio-defenses are a combination of different systems and processes, which are put together in a place by bioscience laboratories, agricultural managers, customs agents, and other professionals to prevent the use of dangerous pathogens and toxins. Examples of these include the regulations that are imposed on the research carried out on certain pathogens, or preparatory plans for the case of a hostile disease outbreak. To build and maintain a successful bio-defense system, laboratories should have a mechanism methodology for the investigation of the outbreak and also a mechanism to prevent a biological attack. This mechanism should comprise primitive, secondary, and tertiary level prevention from the biological attacks.
COVID-19 scenario analysis:
- Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs, such as hydroxychloroquine, have witnessed a dramatic surge in demand for the management of COVID-19.
- Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs as many developed countries are short of these drugs. The pharmaceutical and biotechnology industries are expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19.
- Attributed to such factors, COVID-19 is expected to have a significant impact on the market.
Top impacting factors: Market scenario analysis, trends, drivers, and impact analysis
Governments are taking various initiatives to enhance the readiness against chemical, biological, nuclear and radiological threats, advancements, and adoption through the technological perspective, gene chips being produced for pathogen detection in forensic division, database management systems, nanotechnology, and advanced detector hardware in bio-defense drug development. These are the major factors affecting the bio-defense market positively.
There has been a rise in the frequency of infectious diseases, such as influenza, that has spread a lot of awareness and encouraged pharmaceutical companies to work on R&D for such biological threats. Various programs are also conducted to improvise the scientific research of infectious diseases and create awareness within the public and encourage the population to use public health and be prepared for such biological attacks.
Additionally, the congenital Zika virus infection incidence has helped to boost the investments in the field of bio-defense. Nuclear or radiation weapons are capable of destruction due to their harmful effects, such as radiations, and cause damage equivalent to explosive bombs. To reduce the risk of bio attacks, governments across the world provide funding for medical countermeasures against the attacks to help the market growth positively. Moreover, there has been significant growth in the investments by governments in R&D in North America & European countries. Governments of the Asia-Pacific and Latin American countries are also working on new and favorable initiatives to develop their bio-defense systems. The upgrades in the technological aspect in the biotechnology sector in North America and Europe also contributes to the market growth.
On the other hand, the funding provided for manufacturing vaccines against bioterrorism attacks by authorities in developing and underdeveloped economies is considerably low and hampers the bio-defense market growth.
New product launches and acquisitions to boost the market
On August 8th, 2018, Emergent BioSolutions, Inc. took possession of PaxVax Holding Company Ltd., a developer and manufacturer of vaccines to fight against infectious diseases. In 2018, the U.S. government announced National Bio-defense Strategy and Implementation Plan, the National Defense Strategy, and the National Counterterrorism Strategy, the National Security Strategy, and the National Counter WMD Strategy to provide bio-defense and bio-security to the country. On January 27th, 2017, Emergent BioSolutions Inc. got an approval from the German Federal Ministry of Health, which allowed it to market BioThrax, which was an Anthrax vaccine.
Surge in usage in government and military applications
The major consumers of the bio-defense market are the military and governments of any country. As the governments are closely looking upon the current and future policies and the activities to understand the bio-security and bio-defense threats & preventions, various pharmaceutical companies operating in the bio-defense market have considerable opportunities to expand and be prepared for any bioterrorism.
Key benefits of the report:
- This study presents the analytical depiction of the bio-defense market along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the bio-defense market share.
- The current market is quantitatively analyzed to highlight the bio-defense market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the bio-defense market.
- The report provides a detailed analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the bio-defense market research report:
- Which are the leading market players active in the market?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities of the market?
- What are the projections for the future that would help in taking further strategic steps?
Bio-defense Market, by Product Report Highlights
| Aspects | Details |
 By Product |
|
 By Application |
|
 By End Users |
|
 By Region |
|
 Key Market Players | Nano therapeutics, Inc., Dynavax Technologies Corporation, SIGA Technologies, Inc., Elusys Therapeutics, Inc., Alnylam Pharmaceuticals, Inc., Achaogen, Inc., Ichor Medical Systems, Emergent Bio-Solutions, Inc., Cleveland Biolabs, Dynport Vaccine Company LLC, Bavarian Nordic, PharmAthene, Inc., Xoma Corporation |
Loading Table Of Content...
